NFKB1 and familial dilated cardiomyopathy: Several studies have demonstrated that inhibition of NF-κB signaling pathway can reduce inflammation and oxidative stress, and reduce fibrosis, hypertrophy and apoptosis in vitro and in vivo [80] (Figure 2), thereby preventing DCM.